3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
6
Squamous Cell Carcinoma of Head and Neck
2
Lymphoma, Follicular
2
Head and Neck Neoplasms
2
Recurrence
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell
1
Lymphoma
1
Hereditary Sensory and Autonomic Neuropathies
1
Hematologic Neoplasms
1
Interventions
fludarabine phosphate
19
Peripheral Blood Stem Cell Transplantation
15
Cyclophosphamide
15
Whole-Body Irradiation
14
Tacrolimus
13
Mycophenolic Acid
13
Busulfan
12
Antilymphocyte Serum
11
Rituximab
9
Etoposide
7
Methotrexate
6
Cyclosporine
6
Melphalan
5
thymoglobulin
4
Flow Cytometry
4
Carboplatin
4
Therapeutics
3
Radiotherapy
3
Lenalidomide
3
In Situ Hybridization, Fluorescence
3
Immunohistochemistry
3
Gene Expression Profiling
3
Filgrastim
3
Everolimus
3
Amplified Fragment Length Polymorphism Analysis
3
Alemtuzumab
3
fludarabine
2
Vorinostat
2
Vincristine
2
Transplantation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, Extranodal NK-T-Cell
×
duvelisib
×
Clear all
No trials found.